Shortage reports
Actual shortage:
283 (9%)
Anticipated shortage:
1 (0%)
Avoided shortage:
10 (0%)
Resolved:
2953 (91%)
3247
Discontinuation Reports
To be discontinued:
2 (0%)
Discontinued:
410 (94%)
Reversed:
23 (5%)
435
483 (13%)
16 (6%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-IRBESARTAN | 300MG | TABLET TABLET | Resolved | 2023-06-19 | 2023-07-05 | 195609 |
| TEVA-IRBESARTAN | 75MG | TABLET | Resolved | 2019-08-22 | 2021-05-06 | 92171 |
| TEVA-IRBESARTAN | 75MG | TABLET | Resolved | 2024-01-25 | 2024-04-01 | 217234 |
| TEVA-IRBESARTAN | 150MG | TABLET | Resolved | 2019-09-19 | 2021-09-10 | 94369 |
| TEVA-IRBESARTAN | 75MG | TABLET | Resolved | 2018-12-04 | 2019-06-03 | 68616 |
| TEVA-IRBESARTAN | 300MG | TABLET | Resolved | 2019-07-02 | 2021-09-10 | 88171 |
| TEVA-IRBESARTAN HCTZ | 12.5MG 150MG | TABLET | Resolved | 2018-12-04 | 2019-04-11 | 68619 |
| TEVA-IRBESARTAN HCTZ | 12.5MG 150MG | TABLET | Resolved | 2019-12-19 | 2021-09-10 | 101725 |
| TEVA-IRBESARTAN HCTZ | 25MG 300MG | TABLET | Resolved | 2019-10-24 | 2019-11-28 | 97153 |
| TEVA-IRBESARTAN HCTZ | 25MG 300MG | TABLET | Resolved | 2020-09-22 | 2021-03-04 | 124743 |
| TEVA-IRBESARTAN HCTZ | 300MG 12.5MG | TABLET | Resolved | 2024-04-11 | 2024-06-29 | 224895 |
| TEVA-IRBESARTAN HCTZ | 25MG 300MG | TABLET | Resolved | 2021-03-11 | 2021-05-06 | 135555 |
| TEVA-IRBESARTAN HCTZ | 300MG 25MG | TABLET | Resolved | 2023-11-03 | 2024-03-07 | 209122 |
| TEVA-IRBESARTAN HCTZ | 25MG 300MG | TABLET | Resolved | 2020-07-14 | 2020-07-15 | 120235 |
| TEVA-IRBESARTAN HCTZ | 300MG 25MG | TABLET | Resolved | 2021-06-10 | 2021-09-10 | 140681 |
| TEVA-IRBESARTAN HCTZ | 300MG 25MG | TABLET | Actual shortage | 2024-04-11 | 2024-05-23 | 224898 |
| TEVA-IRBESARTAN HCTZ | 25MG 300MG | TABLET | Resolved | 2020-04-10 | 2021-03-04 | 111865 |
| TEVA-IRBESARTAN HCTZ | 12.5MG 300MG | TABLET | Resolved | 2018-12-04 | 2019-04-11 | 68622 |
| TEVA-IRBESARTAN HCTZ | 12.5MG 150MG | TABLET | Resolved | 2019-07-02 | 2019-11-01 | 88174 |
| TEVA-IRBESARTAN HCTZ | 12.5MG 300MG | TABLET | Resolved | 2019-12-05 | 2021-09-10 | 100305 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-TRIAMTERENE/HCTZ | 25MG 50MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14060 |
| TEVA-TRIAMTERENE/HCTZ | 50MG 25MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115091 |
| TEVA-TRIMEL | 400MG 80MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106133 |
| TEVA-TRIMEL | 400MG 80MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65017 |
| TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65020 |
| TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65023 |
| TEVA-TRYPTOPHAN | 500MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258565 |
| TEVA-TRYPTOPHAN | 1G | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258616 |
| TEVA-TRYPTOPHAN | 500MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258619 |
| TEVA-TRYPTOPHAN | 500MG | TABLET | Discontinued | 2025-06-17 | 2025-06-17 | 260534 |
| TEVA-VALGANCICLOVIR | 450MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258577 |
| TEVA-VALGANCICLOVIR | 450MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258768 |
| TEVA-VALGANCICLOVIR | 450MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258783 |
| TEVA-VALSARTAN | 80MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258496 |
| TEVA-VALSARTAN | 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258501 |
| TEVA-VALSARTAN | 320MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258484 |
| TEVA-VALSARTAN | 160MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258490 |
| TEVA-VALSARTAN | 160MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256152 |
| TEVA-VALSARTAN | 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256155 |
| TEVA-VALSARTAN | 40MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256146 |